Search Results - "Masetti, M."

Spatial agreement of predicted patterns in landslide susceptibility maps by Sterlacchini, S., Ballabio, C., Blahut, J., Masetti, M., Sorichetta, A.

“…The aim of the study is to assess the degree of spatial agreement among different patterns of landslide susceptibility maps with almost similar success and…”
Get full text

Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function by Masetti, M., Montalti, R., Rompianesi, G., Codeluppi, M., Gerring, R., Romano, A., Begliomini, B., Di Benedetto, F., Gerunda, G. E.

“…We designed a randomized trial to assess whether the early withdrawal of cyclosporine (CsA) followed by the initiation of everolimus (Evr) monotherapy in de…”
Get full text

Hemodynamic Effects of Sacubitril-Valsartan in Heart Failure with Reduced-Ejection Fraction: Are All Doses Created Equal? by Masetti, M., Corazza, F., Giovannini, L., Russo, A., Prestinenzi, P., Boschi, S., Potena, L.

“…Paradigm HF trial showed that Sacubitril/Valsartan (LCZ696) 97/103 mg bid reduces the risk of death and hospitalizations for heart failure (HF). We tested the…”
Get full text

Differential Effect of Everolimus on Progression of Early and Late Cardiac Allograft Vasculopathy in Current Clinical Practice by Masetti, M., Potena, L., Nardozza, M., Prestinenzi, P., Taglieri, N., Saia, F., Pece, V., Magnani, G., Fallani, F., Coccolo, F., Russo, A., Rapezzi, C., Grigioni, F., Branzi, A.

“…Randomized trials showed that mTOR inhibitors prevent early development of cardiac allograft vasculopathy (CAV). However, the action of these drugs on CAV late…”
Get full text

Impact of Current Donor Scores Calculation on Heart Transplantation Outcomes by Murana, G., Fiorentino, M., Gliozzi, G., Botta, L., Suarez, S. Martin, Masetti, M., Potena, L., Pacini, D., Loforte, A.

“…Heart transplantation (Htx) remains the gold standard as treatment of patients with advanced heart failure. Donor and recipient characteristics have changed…”
Get full text

Pulmonary Vascular Resistances among Heart Transplant Candidates: Are We Looking to the Right Player? by Masetti, M., Moretta, A., Sabatino, M., Russo, A., Martin Suarez, S., Loforte, A., Galiè, N., Potena, L.

“…Pulmonary vascular resistances (PVR) are among the key measurements derived from right heart catheterization (RHC) in the prognostic assessment of patients…”
Get full text

Using statistical analyses for improving rating methods for groundwater vulnerability in contamination maps by Bonfanti, M., Ducci, D., Masetti, M., Sellerino, M., Stevenazzi, S.

“…With the aim of developing procedures coping with the disadvantages and emphasising the advantages of existing rating methods and the use of statistical…”
Get full text

Impact of Severe Pulmonary Hypertension on Right Heart Hemodynamics and Outcomes Following Cardiac Transplantation: A Single Center Experience by Botta, L., Murana, G., Fiorentino, M., Marianna, B., Gliozzi, G., Masetti, M., Potena, L., Suarez, S. Martin, Pacini, D., Loforte, A.

“…The prognostic impact of pulmonary hypertension (PH) is debated as well as the trend of pulmonary hemodynamic variables after heart transplantation (HTx). We…”
Get full text

Five-year recurrence after endoscopic approach to pilonidal sinus disease: A multicentre experience by Manigrasso, M., D’Amore, A., Benatti, E., Bracchitta, L. M., Bracchitta, S., Cantarella, F., Carpino, A., Ferrari, F., Gallo, G., La Torre, M., Magnani, C., Magni, E., Margiotta, A., Masetti, M., Mori, L., Pata, F., Pezza, M., Tierno, S., Tomassini, F., Vanini, P., De Palma, G. D., Milone, M.

“…Purpose The aim of this study was to evaluate the 5-year recurrence rate of pilonidal sinus disease (PSD) after endoscopic sinusectomy and identify risk…”
Get full text

QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development by Recanatini, Maurizio, Poluzzi, Elisabetta, Masetti, Matteo, Cavalli, Andrea, De Ponti, Fabrizio

“…Prolongation of the QT interval of the electrocardiogram is a typical effect of Class III antiarrhythmic drugs, achieved through blockade of potassium…”
Get full text

Molecular Profiling of Endomyocardial Biopsies and Clinical Phenotype of Graft Dysfunction: Taking Rejection Diagnosis Beyond Pathological Findings by Borgese, L, Gaudenzi, A, Agostini, V, Masetti, M, Corti, B, Reeve, J, Grigioni, F, Leone, O, Halloran, P, Potena, L

Get full text

Predicting Right Ventricular Failure in the Current Continuous Flow Left Ventricular Assist Device Era by Loforte, A, Montalto, A, Polizzi, V, Sbaraglia, F, Presti, M. Lo, Potena, L, Masetti, M, Grigioni, F, Marinelli, G, Musumeci, F

Get full text

Influence of the MELD-XI (Model of End-Stage Liver Disease Excluding INR) on Heart Transplant Outcomes by Loforte, A, Gremolini, M, Cefarelli, M, Jafrancesco, G, Pilato, E, Potena, L, Masetti, M, Grigioni, F, Marinelli, G

Get full text

ICD Therapy Confers No Survival Advantage in a Global LVAD Population: Insights from the Trans-Atlantic Registry on VAD and Transplant (TRAViATA) by Braun, O., Brambatti, M., Shah, P., Cipriani, M., Veenis, J., Bui, Q., Hong, K., de Heyning, C.Van, Perna, E., Timmermans, P., Cikes, M., Gjesdal, G., Partida, C., Potena, L., Masetti, M., Loforte, A., Jakus, N., Nilsson, J., De Bock, D., Minto, J., Brugts, J., Sterken, C., Van den Bossche, K., Rega, F., Sing, R., Russo, C., Pretorius, V., Klein, L., Frigerio, M., Adler, E., Ammirati, E.

“…There are conflicting data related to the use of implantable cardioverter-defibrillators (ICDs) in patients supported with continuous-flow ventricular assist…”
Get full text

Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review by Fiorino, S., Bacchi-Reggiani, L., Sabbatani, S., Grizzi, F., di Tommaso, L., Masetti, M., Fornelli, A., Bondi, A., de Biase, D., Visani, M., Cuppini, A., Jovine, E., Pession, A.

“…Hepatitis B virus (HBV) infection represents a serious global health problem and persistent HBV infection is associated with an increased risk of cirrhosis,…”
Get full text

EUS-guided biliary drainage with placement of a new partially covered biliary stent for palliation of malignant biliary obstruction: a case series by Fabbri, C, Luigiano, C, Fuccio, L, Polifemo, A M, Ferrara, F, Ghersi, S, Bassi, M, Billi, P, Maimone, A, Cennamo, V, Masetti, M, Jovine, E, D'Imperio, N

“…Endoscopic ultrasonography-guided biliary drainage (EUS-BD) has been developed as an alternative drainage technique in patients with obstructive jaundice where…”
Get more information

Risk Stratification to Improve Transplant Benefit in Older Candidates: Are All Comorbidities Created Equal? by Masetti, M, Sabatino, M, Manfredini, V, Borgese, L, Loforte, A, Marinelli, G, Magnani, G, Grigioni, F, Rapezzi, C, Potena, L

Get full text

Quantiferon Monitor: A Novel Assay for Prediction of Infectious Risk in Heart Transplant Recipients by Potena, L, Righini, L, Manfredini, V, Borgese, L, Sgreccia, D, Chiereghin, A, Piccirilli, G, Masetti, M, Lazzarotto, T, Grigioni, F

Get full text

Impact of Pre-Transplant Pulmonary Hypertension Grading on Early- to Long-Term Hemodynamics, Right Venticular Graft Function and Survival After Heart Transplantation by Loforte, A, Barberio, G, Jafrancesco, G, Cefarelli, M, Mariani, C, Potena, L, Masetti, M, Russo, A, Martin Suarez, S, Grigioni, F, Marinelli, G

Get full text

Age Dependent Risk of LVAD Used as a Bridge to Transplant and of Comorbidities on Post-Transplant Survival: An Analysis of ISHLT Registry by Masetti, M, Wilk, A.R, Grigioni, F, Russo, A, Edwards, L.B, Lund, L.H, Stehlik, J, Potena, L

Get full text